Gujarat Biotechnology Research Centre Transfers Cutting-Edge Technologies to Private Sector
Ahmedabad, Gujarat - In a significant stride towards enhancing healthcare diagnostics and veterinary care, the Gujarat Biotechnology Research Centre (GBRC), supported by the state government, has transferred technology for three advanced projects to private companies in Ahmedabad.
The technologies include:
Hereditary Breast and Ovarian Cancer (HBOC) Screening - GBRC has developed a unique diagnostic panel tailored for the Western Indian population. This panel aids in the early detection of gene mutations linked to HBOC, enabling timely interventions. A notable case involved a 14-year-old girl from Rajasthan who was diagnosed with the mutation but tragically succumbed to cancer shortly thereafter.
Muscular Dystrophies (MDs) Diagnosis - Covering nearly 29 of the 50 types prevalent in India, the new diagnostic array at GBRC allows for the identification of genetic markers for MDs through a single blood test, simplifying what previously required multiple tests. This advancement is crucial for early diagnosis, aiding in family planning and early intervention.
Probiotic Treatment for Bovine Endometriosis - Aimed at the dairy sector, this technology introduces a probiotic formulation to treat endometriosis in cows, potentially reducing the reliance on antibiotics and thereby tackling antimicrobial resistance. The animal trials for this technology have been successfully completed.
The transfer of these technologies was facilitated by a new state government policy promoting the commercialization of academic research. "This initiative is a part of our broader strategy to bridge the gap between research and practical application, making advanced diagnostics accessible and commercially viable," stated a senior GBRC official.
These developments not only underscore Gujarat's commitment to fostering innovation in biotechnology but also promise significant health benefits for both human and animal populations. The agreements with Ahmedabad-based firms are expected to lead to wider application and availability of these technologies, thereby enhancing healthcare diagnostics and veterinary care in the region.